D. Haas

Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.

D. Haas, S. S. Case, G. Crooks, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Integrated Self-Inactivating Lentiviral Vectors Produce Full-Length Genomic Transcripts Competent for Encapsidation and Integration

A. Logan, T. Kafri, D. Haas, 2004, Journal of Virology.

Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors.

L. Naldini, D. Haas, S. S. Case, 1999, Proceedings of the National Academy of Sciences of the United States of America.

The Moloney Murine Leukemia Virus Repressor Binding Site Represses Expression in Murine and Human Hematopoietic Stem Cells

A. Logan, C. Lutzko, D. Haas, 2003, Journal of Virology.

Factors influencing the titer and infectivity of lentiviral vectors.

A. Logan, D. Haas, D. Kohn, 2004, Human gene therapy.

Effects of the negative control region on expression from retroviral LTR.

D. Haas, D. Kohn, S. Halene, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors.

L. Naldini, D. Haas, S. S. Case, 1999, Proceedings of the National Academy of Sciences of the United States of America.